Effect of supplemental oxygen exposure on myocardial injury in ST-elevation myocardial infarction
MetadataShow full item record
Objective Supplemental oxygen therapy may increase myocardial injury following ST-elevation myocardial infarction (STEMI). In this study, we aimed to evaluate the effect of the dose and duration of oxygen exposure on myocardial injury after STEMI. Methods Descriptive analysis of data from a multicentre, prospective, randomised, controlled trial of 441 patients with STEMI randomised to supplemental oxygen therapy or room air breathing. The primary endpoint was myocardial infarct size as aeed by cardiac biomarkers, troponin (cTnI) and creatine kinase (CK). Oxygen therapy was commenced by paramedics, and continued for up to 12 h postintervention in hospital. Supplemental oxygen exposure was calculated as the area under the dose×time curve for oxygen administration over the first 12 h, and then aeed for its aociation with cTnI/CK release using multivariable linear regreion. Results The median supplemental oxygen exposure was 1746 L (IQR: 960-2858). After adjustment for potential confounders, every 100 L increase in oxygen exposure in the first 12 h was aociated with a 1.4% (95% CI 0.6% to 2.2%, p<0.001) and 1.2% (95% CI 0.7% to 1.8%, p<0.001) increase in the mean peak cTnI and CK, respectively. Excluding patients who developed cardiogenic shock, recurrent myocardial infarction or desaturations (SpO2<94%) during admiion, every 100 L increase in oxygen exposure was aociated with a 1.2% (95% CI 0.2% to 2.1%, p=0.01) and 1.0% (95% CI 0.3% to 1.7%, p=0.003) increase in the mean peak cTnI and CK, respectively. The median supplemental oxygen exposure of 1746 L would result in a 21% (95% CI 3% to 37%) increase in infarct size according to the cTnI profile. Conclusions Supplemental oxygen exposure in the first 12 h after STEMI was aociated with a clinically significant increase in cTnI and CK release.
Showing items related by title, author, creator and subject.
Stub, D.; Smith, K.; Bernard, S.; Nehme, Z.; Stephenson, M.; Bray, Janet; Cameron, P.; Barger, B.; Ellims, A.; Taylor, A.; Meredith, I.; Kaye, D. (2015)Background: Oxygen is commonly administered to patients with ST-elevation-myocardial infarction despite previous studies suggesting a possible increase in myocardial injury as a result of coronary vasoconstriction and ...
Does the subtype of acute coronary syndrome treated by percutaneous coronary intervention predict long-term clinical outcomes?Biswas, S.; Andrianopoulos, N.; Papapostolou, S.; Noaman, S.; Duffy, S.; Lefkovits, J.; Brennan, Angela; Walton, A.; Shaw, J.; Ajani, A.; Clark, D.; Freeman, M.; Hiew, C.; Oqueli, E.; Reid, C.; Stub, D.; Chan, W. (2018)© The Author 2017. Aims The prognosis of patients undergoing percutaneous coronary intervention (PCI) for different subtypes of acute coronary syndromes (ACS) remains unclear. We compared short- and long-term mortality ...
A randomized controlled trial of oxygen therapy in acute myocardial infarction Air Verses Oxygen in myocarDial infarction study (AVOID Study)Stub, D.; Smith, K.; Bernard, S.; Bray, Janet; Stephenson, M.; Cameron, P.; Meredith, I.; Kaye, D. (2012)Background: The role of routine supplemental oxygen for patients with uncomplicated acute myocardial infarction (AMI) has recently been questioned. There is conflicting data on the possible effects of hyperoxia on ischemic ...